A share price of Vericel Corp [VCEL] is currently trading at $41.45, up 3.32%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VCEL shares have gain 16.89% over the last week, with a monthly amount drifted -0.50%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vericel Corp [NASDAQ: VCEL] stock has seen the most recent analyst activity on August 09, 2024, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $57. Previously, TD Cowen started tracking the stock with Buy rating on June 20, 2024, and set its price target to $55. On January 25, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $51 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $39 on August 08, 2023. BTIG Research downgraded its rating to a Neutral. Truist downgraded its rating to Hold for this stock on November 09, 2022.
Vericel Corp experienced fluctuations in its stock price throughout the past year between $34.87 and $63.00. Currently, Wall Street analysts expect the stock to reach $60.67 within the next 12 months. Vericel Corp [NASDAQ: VCEL] shares were valued at $41.45 at the most recent close of the market. An investor can expect a potential return of 46.37% based on the average VCEL price forecast.
Analyzing the VCEL fundamentals
Trailing Twelve Months sales for Vericel Corp [NASDAQ:VCEL] were 238.54M which represents 2.57% growth. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at 0.01%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is -0.01. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 40.55 points at the first support level, and at 39.65 for the second support level. However, for the 1st resistance point, the stock is sitting at 41.92, and for the 2nd resistance point, it is at 42.39.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vericel Corp [NASDAQ:VCEL] is 5.01. Further, the Quick Ratio stands at 4.58, while the Cash Ratio is 1.86. Considering the valuation of this stock, the price to sales ratio is 8.75, the price to book ratio is 7.05 and price to earnings (TTM) ratio is 1049.37.
Transactions by insiders
Recent insider trading involved Hopper Jonathan Mark, Chief Medical Officer, that happened on Jun 02 ’25 when 10000.0 shares were sold. Officer, Hopper Jonathan Mark completed a deal on Jun 02 ’25 to buy 10000.0 shares. Meanwhile, Former Director GILMAN STEVEN C bought 13125.0 shares on May 30 ’25.